\begin{table}[ht]\footnotesize
  \begin{center}
    \caption{The phenotypes with a high overlap with the BCR(pBLNK)$^+$ compartment as identified by flowType. The table includes the cell proportion of these immunophenotypes (second column) and the differences in the cell proportion of BCR(pBLNK)$^+$ cells in the stimulated and unstimulated assays (third column).}
    \label{apx:BCR}
    \begin{tabular}{lll}
      \hline
      Phenotype Name & Cell Proportion & BCR$^+_{(stim-unstim)}$ \\ 
      \hline
      CD19+CD4-CD8-CD34+CD20+CD123+CD38-CD3- & 0.001 & 0.160 \\ 
      CD19+CD4-CD34+CD20+CD123+CD38-CD3- & 0.001 & 0.160 \\ 
      CD19+CD4-CD34+CD20+CD123+CD3- & 0.001 & 0.155 \\ 
      \hline
    \end{tabular}
  \end{center}
\end{table}

% latex table generated in R 2.14.1 by xtable 1.7-0 package
% Mon Mar 19 12:59:47 2012
\begin{table}[ht]\footnotesize
  \begin{center}
    \caption{The phenotypes with a high overlap with the IL7(pSTAT5)$^+$ compartment as identified by flowType. The table includes the cell proportion of these immunophenotypes (second column) and differences in the cell proportion of IL7(pSTAT5)$^+$ cells in the stimulated and unstimulated assays (third column).}
    \label{apx:IL7}
    \begin{tabular}{lll}
      \hline
      Phenotype Name & Cell Proportion & IL7$^+_{(stim-unstim)}$ \\ 
      \hline
        CD19-CD4+CD8+CD20+CD33+CD38-CD3+ & 0.008 & 0.364 \\ 
        CD19-CD4+CD8+CD20+CD33+CD3+ & 0.008 & 0.366 \\ 
        CD19-CD4+CD8+CD34+CD33+CD38-CD3+ & 0.008 & 0.366 \\ 
        CD19-CD4+CD8+CD34+CD33+CD3+ & 0.008 & 0.368 \\ 
        CD19-CD4+CD8+CD34+CD20+CD33+CD38-CD3+ & 0.006 & 0.399 \\ 
        CD19-CD4+CD8+CD34+CD20+CD33+CD3+ & 0.006 & 0.402 \\ 
        CD4+CD8+CD20+CD33+CD38-CD3+ & 0.011 & 0.365 \\ 
        CD4+CD8+CD20+CD33+CD3+ & 0.011 & 0.371 \\ 
        CD4+CD8+CD34+CD33+CD38-CD3+ & 0.011 & 0.366 \\ 
        CD4+CD8+CD34+CD33+CD3+ & 0.011 & 0.371 \\ 
        CD4+CD8+CD34+CD20+CD33+CD38-CD3+ & 0.008 & 0.399 \\ 
        CD4+CD8+CD34+CD20+CD33+CD3+ & 0.009 & 0.405 \\ 
        CD19+CD4+CD8+CD20+CD33+CD38-CD3+ & 0.003 & 0.364 \\ 
        CD19+CD4+CD8+CD20+CD33+CD3+ & 0.003 & 0.378 \\ 
        CD19+CD4+CD8+CD34+CD33+CD38-CD3+ & 0.003 & 0.359 \\ 
        CD19+CD4+CD8+CD34+CD33+CD3+ & 0.003 & 0.372 \\ 
        CD19+CD4+CD8+CD34+CD20+CD33+CD38-CD3+ & 0.002 & 0.397 \\ 
        CD19+CD4+CD8+CD34+CD20+CD33+CD3+ & 0.002 & 0.409 \\ 
      \hline
    \end{tabular}
  \end{center}
\end{table}


% latex table generated in R 2.14.1 by xtable 1.7-0 package
% Mon Mar 19 12:55:05 2012
\begin{table}[ht]\footnotesize
  \begin{center}
    \caption{The phenotypes with a high overlap with the LPS(p-p38)$^+$ compartment as identified by flowType. The table includes the cell proportion of these immunophenotypes (second column) and differences in the cell proportion of LPS(p-p38)$^+$ cells in the stimulated and unstimulated assays (third column).}
    \label{apx:LPS}
    \begin{tabular}{lll}
      \hline
      Phenotype Name & Cell Proportion & LPS$^+_{(stim-unstim)}$ \\ 
      \hline
      CD19-CD4-CD8-CD34-CD20-CD33+CD123-CD38-CD3- & 0.008 & 0.474 \\ 
      CD19-CD4-CD8-CD34-CD20-CD33+CD123-CD3- & 0.008 & 0.473 \\ 
      CD19-CD4-CD8-CD34-CD20-CD33+CD38-CD3- & 0.009 & 0.466 \\ 
      CD19-CD4-CD8-CD34-CD20-CD33+CD3- & 0.009 & 0.465 \\ 
      CD19-CD4-CD8-CD34-CD33+CD123-CD38-CD3- & 0.022 & 0.460 \\ 
      CD19-CD4-CD8-CD34-CD33+CD123-CD3- & 0.022 & 0.459 \\ 
      CD19-CD4-CD8-CD34-CD33+CD38-CD3- & 0.022 & 0.452 \\ 
      CD19-CD4-CD8-CD34-CD33+CD3- & 0.022 & 0.451 \\ 
      CD19-CD4-CD8-CD34-CD20+CD33+CD123-CD38-CD3- & 0.013 & 0.450 \\ 
      CD19-CD4-CD8-CD34-CD20+CD33+CD123-CD3- & 0.013 & 0.449 \\ 
      CD19-CD4-CD8-CD20-CD33+CD123-CD38-CD3- & 0.023 & 0.453 \\ 
      CD19-CD4-CD8-CD20-CD33+CD123-CD3- & 0.023 & 0.452 \\ 
      CD19-CD4-CD34-CD20-CD33+CD123-CD38-CD3- & 0.011 & 0.456 \\ 
      CD19-CD4-CD34-CD20-CD33+CD123-CD3- & 0.011 & 0.455 \\ 
      CD19-CD8-CD34-CD20-CD33+CD123-CD38-CD3- & 0.012 & 0.462 \\ 
      CD19-CD8-CD34-CD20-CD33+CD123-CD3- & 0.012 & 0.461 \\ 
      CD19-CD8-CD34-CD20-CD33+CD38-CD3- & 0.012 & 0.454 \\ 
      CD19-CD8-CD34-CD20-CD33+CD3- & 0.012 & 0.454 \\ 
      CD4-CD8-CD34-CD20-CD33+CD123-CD38-CD3- & 0.011 & 0.462 \\ 
      CD4-CD8-CD34-CD20-CD33+CD123-CD3- & 0.011 & 0.461 \\ 
      CD4-CD8-CD34-CD20-CD33+CD38-CD3- & 0.011 & 0.454 \\ 
      CD4-CD8-CD34-CD20-CD33+CD3- & 0.011 & 0.454 \\ 
      CD8-CD34-CD20-CD33+CD123-CD38-CD3- & 0.015 & 0.450 \\ 
      CD8-CD34-CD20-CD33+CD123-CD3- & 0.015 & 0.449 \\ 
      \hline
    \end{tabular}
  \end{center}
\end{table}

% latex table generated in R 2.11.1 by xtable 1.5-6 package
% Sat Dec 11 12:28:36 2010
% \begin{table}\tiny
\begin{landscape}
\begin{center}
  {\tiny 
    % \begin{longtable}{rp{6cm}lllll}
    \begin{longtable}{rlllllll}
      \caption{\normalsize Statistically significant immunophenotypic correlates of survival of HIV$^+$ subjects are predicted by flowType. The p-values of the log rank tests, 95\% confidence intervals calculated using bootstrapping, adjusted p-values using Bonferroni's method, coefficients and $R^2$ values of the Cox proportional hazards regression models, and the frequency of the cells are provided as columns of the table.}\\
 \hline
      \# & Phenotype & p-value & p-value, CI & adjusted & CPHR & R$^2$ & Cell \\
      &  & & & p-value & Coefficient &  & Frequency \\
      \hline
      \endhead
      1 & CD28-CD45RO+CD57-CCR5+ & 5.3e-07 & (4.3e-14, 1.3e-02) & 2e-02 &  20.5 & 0.056 & 0.03048 \\ 
      2 & CD28-CD8+CD57-CD127- & 2.5e-07 & (2.3e-14, 3.8e-04) & 1e-02 &  12.3 & 0.060 & 0.05975 \\ 
      3 & CD28-CD45RO+CD57-CCR7- & 5.1e-07 & (2.3e-14, 6.1e-04) & 2e-02 &  15.7 & 0.057 & 0.03829 \\ 
      4 & CD28-CD45RO+CD4-CD57- & 3.5e-07 & (2.3e-14, 1.1e-03) & 1e-02 &  13.2 & 0.058 & 0.04357 \\ 
      5 & CD45RO+CD4-CD57-CD127- & 2.7e-07 & (1.2e-13, 7.1e-03) & 1e-02 &  12.8 & 0.059 & 0.05062 \\ 
      6 & CD28-CD45RO+CD57-CD127- & 4.7e-08 & (1.7e-14, 6.8e-04) & 2e-03 &  16.0 & 0.067 & 0.03732 \\ 
      7 & CD45RO+CD4-CD27-CD127- & 4.4e-07 & (5.8e-14, 1.1e-03) & 2e-02 &  14.3 & 0.057 & 0.04830 \\ 
      8 & CD28-CD45RO+CD57- & 5.6e-07 & (4.4e-14, 4.1e-04) & 2e-02 &  12.4 & 0.056 & 0.05015 \\ 
      9 & CD45RO+CD4-CD127- & 6.5e-07 & (4.7e-15, 2.9e-03) & 2e-02 &   9.6 & 0.056 & 0.07176 \\ 
      10 & CD28-CD45RO+CD4-CD127- & 3.1e-07 & (0.0e+00, 5.7e-03) & 1e-02 &  11.7 & 0.059 & 0.05300 \\ 
      11 & CD28-CD45RO+CD57-CCR5+CD27-CCR7+CD127- & 4.7e-07 & (5.7e-14, 7.7e-03) & 2e-02 & 171.4 & 0.057 & 0.00315 \\ 
      12 & CD28-CD45RO+CD4-CD57-CCR5+CD27-CCR7+CD127- & 4.5e-07 & (1.8e-13, 3.9e-04) & 2e-02 & 176.2 & 0.057 & 0.00294 \\ 
      13 & CD28-CD57-CD127- & 3.3e-07 & (3.4e-15, 8.0e-03) & 1e-02 &   8.0 & 0.058 & 0.12341 \\ 
      14 & CD28-CD4-CD57- & 8.8e-07 & (2.2e-15, 2.9e-03) & 3e-02 &   7.2 & 0.054 & 0.15525 \\ 
      15 & CD57-CD27-CD127- & 6.2e-08 & (2.4e-14, 4.7e-03) & 2e-03 &   9.5 & 0.065 & 0.12173 \\ 
      16 & CD4-CD57-CD27-CD127- & 4.7e-08 & (4.2e-14, 3.3e-03) & 2e-03 &   9.7 & 0.067 & 0.09721 \\ 
      17 & CD28-CD57-CCR7-CD127- & 2.8e-07 & (9.7e-15, 1.0e-02) & 1e-02 &   9.8 & 0.059 & 0.08417 \\ 
      18 & CD28-CD4-CD57-CD127- & 3.3e-08 & (2.0e-12, 5.7e-04) & 1e-03 &   9.1 & 0.068 & 0.10852 \\ 
      19 & CD4-CD57-CCR7-CD127- & 6.5e-07 & (3.8e-15, 2.3e-03) & 2e-02 &   8.8 & 0.056 & 0.09501 \\ 
      20 & CD45RO-CD4-CD57+CCR5-CD27+CCR7-CD127- & 6.1e-07 & (1.2e-12, 2.6e-03) & 2e-02 & 498.4 & 0.056 & 0.00097 \\ 
      21 & CD28-CD45RO-CD4-CD57+CCR5-CD27+CCR7-CD127- & 2.5e-07 & (0.0e+00, 7.7e-03) & 1e-02 & 561.2 & 0.060 & 0.00074 \\ 
      22 & CD45RO-CD8+CD57+CCR5-CD27+CCR7-CD127- & 1.2e-07 & (4.6e-14, 3.3e-04) & 5e-03 & 638.6 & 0.063 & 0.00068 \\ 
      23 & CD45RO-CD8+CD4-CD57+CCR5-CD27+CCR7-CD127- & 1.2e-07 & (5.1e-14, 2.0e-03) & 5e-03 & 638.6 & 0.063 & 0.00068 \\ 
      24 & CD28-CD45RO-CD4-CD57+CCR5-CD27+CD127- & 5.7e-07 & (1.1e-13, 2.3e-03) & 2e-02 & 298.3 & 0.056 & 0.00099 \\ 
      25 & KI-67+CD28-CCR5+ & 1.0e-11 & (2.9e-13, 2.8e-03) & 4e-07 &  96.1 & 0.101 & 0.00547 \\ 
      26 & KI-67+CD28-CCR5+CD27- & 8.7e-12 & (1.5e-14, 8.9e-04) & 3e-07 & 115.3 & 0.102 & 0.00453 \\ 
      27 & KI-67+CCR5+ & 1.3e-11 & (2.4e-14, 7.0e-03) & 5e-07 &  53.4 & 0.100 & 0.01192 \\ 
      28 & KI-67+CD28+CD45RO+CD57-CCR7-CD127- & 4.2e-09 & (5.6e-16, 3.0e-03) & 2e-04 & 241.3 & 0.077 & 0.00209 \\ 
      29 & KI-67+CD45RO-CD4-CD27-CCR7-CD127- & 1.2e-09 & (2.0e-14, 4.4e-03) & 4e-05 & 161.9 & 0.082 & 0.00297 \\ 
      30 & KI-67+CD28-CD45RO-CD8-CD4- & 5.0e-09 & (2.9e-12, 1.7e-03) & 2e-04 & 176.0 & 0.076 & 0.00225 \\ 
      31 & KI-67+CD8-CD4- & 8.1e-09 & (6.1e-13, 4.5e-02) & 3e-04 &  58.1 & 0.074 & 0.00738 \\ 
      32 & KI-67+CCR5+CD27-CCR7- & 2.0e-11 & (3.8e-14, 6.0e-04) & 8e-07 & 109.8 & 0.099 & 0.00532 \\ 
      33 & KI-67+CD8-CCR5+CCR7- & 1.3e-10 & (3.1e-13, 2.0e-03) & 5e-06 & 147.3 & 0.091 & 0.00392 \\ 
      34 & KI-67+CD28-CD8-CCR5+CCR7+CD127- & 2.6e-09 & (1.6e-14, 1.1e-02) & 1e-04 & 625.8 & 0.079 & 0.00061 \\ 
      35 & KI-67+CD28+CD45RO+CD8+CD57-CD27+CCR7+ & 6.7e-07 & (3.8e-13, 1.5e-03) & 3e-02 & 585.4 & 0.055 & 0.00051 \\ 
      36 & KI-67+CD28+CD45RO+CD8+CD4-CD57-CD27+CCR7+ & 6.7e-07 & (1.1e-16, 4.7e-03) & 3e-02 & 585.4 & 0.055 & 0.00051 \\ 
      37 & KI-67+CD8+CD27-CCR7-CD127- & 4.7e-11 & (1.3e-13, 1.4e-03) & 2e-06 & 141.3 & 0.095 & 0.00292 \\ 
      38 & KI-67+CD8+CD4-CD27-CCR7-CD127- & 4.7e-11 & (1.3e-13, 1.3e-03) & 2e-06 & 141.3 & 0.095 & 0.00292 \\ 
      39 & KI-67+CD28-CD8+CD27-CCR7-CD127- & 2.7e-11 & (1.0e-13, 7.6e-04) & 1e-06 & 164.5 & 0.097 & 0.00241 \\ 
      40 & KI-67+CD28-CD8+CD4-CD27-CCR7-CD127- & 2.7e-11 & (2.7e-13, 1.4e-03) & 1e-06 & 164.5 & 0.097 & 0.00241 \\ 
      41 & KI-67+CD28-CD8+CCR7-CD127- & 6.6e-11 & (5.6e-14, 1.5e-02) & 3e-06 & 132.9 & 0.094 & 0.00293 \\ 
      42 & KI-67+CD28-CD8+CD4-CCR7-CD127- & 6.6e-11 & (1.2e-14, 8.4e-04) & 3e-06 & 132.9 & 0.094 & 0.00293 \\ 
      43 & KI-67+CD45RO+CD8+CD27-CCR7- & 1.2e-09 & (4.0e-12, 2.8e-03) & 5e-05 & 143.6 & 0.082 & 0.00216 \\ 
      44 & KI-67+CD45RO+CD8+CD4-CD27-CCR7- & 1.2e-09 & (1.0e-12, 1.2e-02) & 5e-05 & 143.6 & 0.082 & 0.00216 \\ 
      45 & KI-67+CD28-CD45RO+CD8+CD27-CCR7- & 1.0e-09 & (1.9e-15, 7.3e-04) & 4e-05 & 188.5 & 0.082 & 0.00155 \\ 
      46 & KI-67+CD28-CD45RO+CD8+CD4-CD27-CCR7- & 1.0e-09 & (1.7e-13, 2.0e-03) & 4e-05 & 188.5 & 0.082 & 0.00155 \\ 
      47 & KI-67+CD45RO+CD8+CD27-CD127- & 7.1e-10 & (1.2e-14, 6.8e-03) & 3e-05 & 152.4 & 0.084 & 0.00221 \\ 
      48 & KI-67+CD45RO+CD8+CD4-CD27-CD127- & 7.1e-10 & (3.4e-14, 1.5e-03) & 3e-05 & 152.4 & 0.084 & 0.00221 \\ 
      49 & KI-67+CD28-CD45RO+CD8+CD27-CD127- & 5.0e-10 & (6.0e-13, 3.1e-03) & 2e-05 & 201.3 & 0.085 & 0.00163 \\ 
      50 & KI-67+CD28-CD45RO+CD8+CD4-CD27-CD127- & 5.0e-10 & (4.6e-14, 2.7e-03) & 2e-05 & 201.3 & 0.085 & 0.00163 \\ 
      51 & KI-67+CD28-CD45RO+CD8+CD127- & 1.0e-09 & (1.2e-15, 3.2e-03) & 4e-05 & 150.5 & 0.083 & 0.00222 \\ 
      52 & KI-67+CD28-CD45RO+CD8+CD4-CD127- & 1.0e-09 & (1.5e-11, 3.6e-03) & 4e-05 & 150.5 & 0.083 & 0.00222 \\ 
      53 & KI-67+CD45RO+CD8+CD4-CD127- & 2.2e-09 & (2.8e-13, 2.1e-03) & 9e-05 &  99.8 & 0.079 & 0.00362 \\ 
      54 & KI-67+CD28-CD45RO+CD8+CD4-CCR7- & 8.0e-09 & (2.7e-12, 7.2e-04) & 3e-04 & 133.6 & 0.074 & 0.00209 \\ 
      55 & KI-67+CD28-CD45RO+CD57-CCR7+CD127- & 5.9e-08 & (4.0e-15, 4.5e-03) & 2e-03 & 376.6 & 0.066 & 0.00075 \\ 
      56 & KI-67+CD28-CD45RO+CD4-CD57-CCR7+CD127- & 5.0e-08 & (4.8e-13, 3.9e-03) & 2e-03 & 409.6 & 0.066 & 0.00070 \\ 
      57 & KI-67+CD57-CD27-CD127- & 5.9e-10 & (3.2e-14, 2.7e-03) & 2e-05 &  44.9 & 0.085 & 0.00806 \\ 
      58 & KI-67+CD28-CD27-CD127- & 4.8e-10 & (7.3e-15, 2.5e-03) & 2e-05 &  50.6 & 0.086 & 0.00711 \\ 
      59 & KI-67+CD4-CD127- & 1.3e-10 & (4.4e-16, 9.7e-03) & 5e-06 &  37.1 & 0.091 & 0.01159 \\ 
      60 & KI-67+CD28-CD127- & 4.9e-10 & (1.1e-12, 1.4e-03) & 2e-05 &  41.4 & 0.086 & 0.00823 \\ 
      61 & KI-67+CD4-CD27- & 5.6e-09 & (2.1e-14, 2.6e-03) & 2e-04 &  28.6 & 0.075 & 0.01122 \\ 
      62 & KI-67+CD28-CD4-CD27- & 1.8e-09 & (3.6e-13, 5.3e-03) & 7e-05 &  40.2 & 0.080 & 0.00785 \\ 
      63 & KI-67+CD27-CD127- & 1.3e-09 & (9.8e-15, 1.1e-03) & 5e-05 &  33.0 & 0.082 & 0.01052 \\ 
      64 & KI-67+CCR7-CD127- & 6.5e-11 & (1.4e-15, 9.6e-04) & 2e-06 &  47.3 & 0.094 & 0.00947 \\ 
      65 & KI-67+CD4-CD27-CCR7- & 9.6e-11 & (1.1e-16, 1.5e-03) & 4e-06 &  52.1 & 0.092 & 0.00764 \\ 
      66 & KI-67+CD4-CCR7- & 1.7e-10 & (3.0e-14, 1.0e-02) & 7e-06 &  41.4 & 0.090 & 0.00987 \\ 
      67 & KI-67+CD45RO+CD57-CCR7- & 1.4e-09 & (6.6e-13, 1.2e-03) & 5e-05 &  49.6 & 0.081 & 0.00695 \\ 
      68 & KI-67+CD45RO+CD57-CD27-CCR7- & 9.1e-10 & (8.6e-12, 2.5e-03) & 3e-05 &  66.4 & 0.083 & 0.00505 \\ 
      69 & KI-67+CD45RO+CD4- & 2.0e-09 & (8.0e-13, 2.5e-03) & 8e-05 &  45.3 & 0.080 & 0.00851 \\ 
      70 & KI-67+CD28-CD45RO+ & 1.3e-08 & (1.2e-12, 2.4e-03) & 5e-04 &  54.9 & 0.072 & 0.00525 \\ 
      71 & KI-67+CD45RO+CD127- & 1.1e-09 & (4.4e-16, 1.5e-02) & 4e-05 &  42.5 & 0.082 & 0.00834 \\ 
      72 & KI-67+CD45RO+CD57-CD127- & 2.9e-10 & (1.5e-14, 6.4e-04) & 1e-05 &  55.0 & 0.088 & 0.00719 \\ 
      73 & KI-67+CD28-CD45RO+CD8+CD27- & 9.2e-09 & (2.6e-15, 2.3e-03) & 4e-04 & 138.0 & 0.073 & 0.00201 \\ 
      74 & KI-67+CD28-CD45RO+CD8+CD4-CD27- & 9.2e-09 & (1.0e-15, 4.6e-03) & 4e-04 & 138.0 & 0.073 & 0.00201 \\ 
      75 & KI-67+CD8+CD4-CD57-CD27-CD127- & 1.9e-09 & (5.9e-14, 7.0e-03) & 7e-05 & 113.8 & 0.080 & 0.00274 \\ 
      76 & KI-67+CD28-CD45RO+CD8+ & 9.3e-09 & (5.9e-13, 1.4e-03) & 4e-04 & 102.7 & 0.073 & 0.00279 \\ 
      77 & KI-67+CD28-CD45RO+CD8+CD4- & 9.3e-09 & (0.0e+00, 1.6e-03) & 4e-04 & 102.7 & 0.073 & 0.00279 \\ 
      78 & KI-67+CD45RO+CD8+ & 2.1e-08 & (6.9e-15, 6.8e-04) & 8e-04 &  59.1 & 0.070 & 0.00512 \\ 
      79 & KI-67+CD8+CCR7- & 3.0e-08 & (7.7e-13, 2.8e-03) & 1e-03 &  49.5 & 0.068 & 0.00530 \\ 
      80 & KI-67+CD8+CD27-CCR7- & 8.3e-09 & (1.0e-13, 3.6e-03) & 3e-04 &  70.7 & 0.074 & 0.00377 \\ 
      81 & KI-67+CD4- & 2.8e-08 & (1.0e-13, 2.3e-03) & 1e-03 &  17.1 & 0.069 & 0.01627 \\ 
      82 & KI-67+CD28-CD4- & 1.1e-08 & (5.9e-14, 4.0e-03) & 4e-04 &  26.7 & 0.073 & 0.00950 \\ 
      83 & KI-67+CD127- & 2.7e-08 & (1.2e-12, 2.1e-03) & 1e-03 &  19.1 & 0.069 & 0.01460 \\ 
      84 & KI-67+CCR7- & 8.4e-08 & (3.4e-15, 2.3e-03) & 3e-03 &  18.3 & 0.064 & 0.01311 \\ 
      85 & KI-67+CD27-CCR7- & 3.5e-08 & (1.7e-13, 1.2e-03) & 1e-03 &  25.2 & 0.068 & 0.00998 \\ 
      86 & KI-67+CD45RO+CD27- & 7.5e-07 & (5.4e-13, 1.8e-03) & 3e-02 &  24.0 & 0.055 & 0.00862 \\ 
      87 & KI-67+CD45RO+CD57- & 1.2e-07 & (2.1e-13, 3.1e-03) & 5e-03 &  22.9 & 0.062 & 0.01123 \\ 
      88 & KI-67+CD4-CD57- & 1.3e-08 & (3.8e-15, 2.1e-03) & 5e-04 &  25.3 & 0.072 & 0.01209 \\ 
      89 & KI-67+CD28-CD4-CD57- & 9.7e-09 & (5.5e-12, 1.2e-03) & 4e-04 &  37.7 & 0.073 & 0.00698 \\ 
      90 & KI-67+CD57-CD127- & 3.3e-09 & (1.3e-13, 3.3e-03) & 1e-04 &  28.1 & 0.078 & 0.01128 \\ 
      91 & KI-67+CD45RO+CCR7- & 4.2e-09 & (7.8e-15, 2.5e-03) & 2e-04 &  37.5 & 0.077 & 0.00819 \\ 
      92 & KI-67+CD57-CCR7- & 2.7e-08 & (2.8e-13, 2.8e-03) & 1e-03 &  26.6 & 0.069 & 0.01008 \\ 
      93 & KI-67+CD57-CD27-CCR7- & 1.2e-08 & (4.9e-13, 2.6e-03) & 5e-04 &  36.8 & 0.072 & 0.00762 \\ 
      94 & KI-67+CD28-CCR7- & 3.3e-09 & (4.6e-14, 5.7e-03) & 1e-04 &  37.7 & 0.078 & 0.00739 \\ 
      95 & KI-67+CD28-CD27-CCR7- & 3.3e-09 & (2.6e-14, 6.5e-04) & 1e-04 &  43.0 & 0.078 & 0.00647 \\ 
      96 & KI-67+CD28- & 1.9e-07 & (4.0e-15, 2.7e-03) & 7e-03 &  18.3 & 0.061 & 0.01053 \\ 
      97 & KI-67+CD28-CD27- & 7.1e-08 & (1.5e-12, 8.6e-04) & 3e-03 &  26.3 & 0.065 & 0.00874 \\ 
      98 & KI-67+CD28-CD8- & 8.3e-08 & (5.5e-14, 2.5e-03) & 3e-03 &  44.2 & 0.064 & 0.00523 \\ 
      99 & KI-67+CD45RO+ & 8.9e-07 & (1.9e-13, 2.5e-03) & 3e-02 &  15.4 & 0.054 & 0.01343 \\ 
      100 & KI-67+CD8+CD57- & 1.1e-06 & (4.4e-14, 3.1e-03) & 4e-02 &  28.3 & 0.053 & 0.00648 \\ 
      101 & KI-67+CD8+CD27- & 6.4e-07 & (2.3e-14, 1.1e-02) & 2e-02 &  35.2 & 0.056 & 0.00560 \\ 
      \hline
      \label{apx:tsl}
      % \end{table}
    \end{longtable}
  }
\end{center}
\end{landscape}
